These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 18516602)

  • 1. Myelodysplastic syndromes: molecular pathogenesis and genomic changes.
    Nolte F; Hofmann WK
    Ann Hematol; 2008 Oct; 87(10):777-95. PubMed ID: 18516602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Important features of myelodysplastic syndrome.
    Hofmann WK; Koeffler HP
    Int J Hematol; 2002 Aug; 76 Suppl 2():222-7. PubMed ID: 12430929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms involved in the progression of myelodysplastic syndrome.
    Nolte F; Hofmann WK
    Future Oncol; 2010 Mar; 6(3):445-55. PubMed ID: 20222800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refractory anemia and the myelodysplastic syndromes.
    Lawrence LW
    Clin Lab Sci; 2004; 17(3):178-86. PubMed ID: 15314893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular basis of myelodysplastic syndromes.
    Gallagher A; Darley RL; Padua R
    Haematologica; 1997; 82(2):191-204. PubMed ID: 9175327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Myelodysplastic syndromes].
    Geissler K
    Wien Med Wochenschr; 1991; 141(9-10):201-4. PubMed ID: 1949844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative review of classification systems in myelodysplastic syndromes (MDS).
    Bennett JM
    Semin Oncol; 2005 Aug; 32(4 Suppl 5):S3-10. PubMed ID: 16085011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular bases of myelodysplastic syndromes: lessons from animal models.
    Komeno Y; Kitaura J; Kitamura T
    J Cell Physiol; 2009 Jun; 219(3):529-34. PubMed ID: 19259975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and epigenetic alterations in myelodysplastic syndrome.
    Mihara K; Takihara Y; Kimura A
    Cytogenet Genome Res; 2007; 118(2-4):297-303. PubMed ID: 18000383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear inositide signaling in myelodysplastic syndromes.
    Follo MY; Mongiorgi S; Finelli C; Clissa C; Ramazzotti G; Fiume R; Faenza I; Manzoli L; Martelli AM; Cocco L
    J Cell Biochem; 2010 Apr; 109(6):1065-71. PubMed ID: 20058233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classification and prognostic evaluation of myelodysplastic syndromes.
    Cazzola M; Della Porta MG; Travaglino E; Malcovati L
    Semin Oncol; 2011 Oct; 38(5):627-34. PubMed ID: 21943669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Myelodysplastic syndromes].
    Solary E; Fontenay M
    Rev Prat; 2010 Dec; 60(10):1408-9, 1412. PubMed ID: 21425540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of AURKA and AURKB genes in bone marrow stromal mesenchymal cells of myelodysplastic syndrome: correlation with G-banding analysis and FISH.
    Oliveira FM; Lucena-Araujo AR; Favarin Mdo C; Palma PV; Rego EM; Falcão RP; Covas DT; Fontes AM
    Exp Hematol; 2013 Feb; 41(2):198-208. PubMed ID: 23092930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear phospholipase C beta1, regulation of the cell cycle and progression of acute myeloid leukemia.
    Cocco L; Manzoli L; Palka G; Martelli AM
    Adv Enzyme Regul; 2005; 45():126-35. PubMed ID: 16024064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis, classification, and course of myelodysplastic syndromes.
    McKenna RW; Allison PM
    Clin Lab Med; 1990 Dec; 10(4):683-706. PubMed ID: 2272170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Contemporary possibilities of prognosis in myelodysplastic syndromes].
    Goździk J; Lewandowski K; Hansz J
    Acta Haematol Pol; 1995; 26(2):129-38. PubMed ID: 7653217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology, classification and prognosis of adults and children with myelodysplastic syndromes.
    Germing U; Aul C; Niemeyer CM; Haas R; Bennett JM
    Ann Hematol; 2008 Sep; 87(9):691-9. PubMed ID: 18575866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of secondary hematologic disorders: preMDS-->MDS-->sAML.
    Preisler HD
    Cancer Treat Res; 2001; 108():185-230. PubMed ID: 11702600
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular and genetic features of myelodysplastic syndromes.
    Greenberg PL
    Int J Lab Hematol; 2012 Jun; 34(3):215-22. PubMed ID: 22212119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.